decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
Appendix E - National Coverage Determinations Manual / SEROLOGIC_TESTING_FOR_ACQUIRED_IMMUNODEFICIENCY_SYNDROME_(AIDS)
Subscribe or sign in to view the full article.
Article Overview
This article summarizes a National Coverage Determination Manual entry on serologic testing for AIDS/HIV. It explains the general purpose of the testing, the kinds of immunoassay approaches discussed, and the coverage context tied to symptomatic versus screening use. The page is relevant for coders, billers, and compliance staff who need to understand how Medicare frames coverage for this type of laboratory testing.
Why This Topic Matters
Understanding this coverage guidance helps organizations align laboratory billing and documentation with Medicare policy for AIDS/HIV serologic testing. It is especially useful for teams working with diagnostic laboratory services, medical necessity review, and payer compliance.
What You Will Learn
- The Medicare coverage context for serologic testing related to AIDS/HIV
- The general laboratory methods discussed in the policy
- The difference between diagnostic and screening context at a high level
- The effective date associated with the coverage entry
Who Should Read This
- Medical coders
- Billers
- Compliance staff
- Laboratory billing teams
- Revenue cycle staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com